The preliminary results of a study to estimate the level of cytosol oestrogen and progesterone receptors in the lower urinary tract are presented. 29 full thickness biopsies were obtained from the vault, trigone and urethra of 9 female surgical patients aged 13–72 years. Cytosol assay for oestradiol-17Β receptors and progesterone receptors was performed. Oestrogen receptors were present in all 5 urethral specimens examined and with a consistently higher concentration in the middle and distal thirds in comparison to the proximal urethra. In only 1 of the 9 vault specimens and 8 trigone specimens were receptors found and those in small quantities. No progesterone receptors were determined in any of the vault, trigone and urethral specimens examined. The presence of oestrogen receptors in the middle and distal thirds of the human female urethra is strong supportive evidence of the sensitivity of the urethra to oestrogens, and the higher concentration of those receptors in these sites in comparison to the proximal urethra, vault and trigone confirms the common embryological origin of the distal urethra and vagina from the definitive urogenital sinus. The absence of measurable progesterone receptors in all the lower urinary tract specimens examined is discussed.

Keywords:
Oestrogen, Progesterone, Receptors, Human, Urethra, Bladder
This content is only available via PDF.
© 1984 S. Karger AG, Basel
1984
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.